Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arteris (AIP) Cash & Equivalents (2023 - 2025)

Arteris' Cash & Equivalents history spans 3 years, with the latest figure at $33.9 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 147.74% year-over-year to $33.9 million; the TTM value through Dec 2025 reached $33.9 million, up 147.74%, while the annual FY2025 figure was $33.9 million, 147.74% up from the prior year.
  • Cash & Equivalents reached $33.9 million in Q4 2025 per AIP's latest filing, up from $17.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $33.9 million in Q4 2025 to a low of $13.7 million in Q4 2024.
  • Average Cash & Equivalents over 3 years is $20.9 million, with a median of $18.2 million recorded in 2023.
  • The largest YoY upside for Cash & Equivalents was 147.74% in 2025 against a maximum downside of 37.32% in 2025.
  • A 3-year view of Cash & Equivalents shows it stood at $13.7 million in 2023, then decreased by 0.09% to $13.7 million in 2024, then surged by 147.74% to $33.9 million in 2025.
  • Per Business Quant, the three most recent readings for AIP's Cash & Equivalents are $33.9 million (Q4 2025), $17.4 million (Q3 2025), and $16.1 million (Q2 2025).